BARINTHUS BIOTHERAPEUTICS PLC revenue for the last year amounted to 724.81 k EUR, the most of which — 726.62 k EUR — came from its highest performing source at the moment, Immunotherapies and Vaccines, the year earlier bringing 41.77 M EUR. The greatest contribution to the revenue figure was made by United Kingdom and United States — last year it brought BARINTHUS BIOTHERAPEUTICS PLC 726.62 k EUR, and the year before that — 41.77 M EUR.